Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Quinidine syncope. A report of successful treatment with bretylium tosylate.

VanderArk CR, Reynolds EW, Kahn DR, Tullett G.

J Thorac Cardiovasc Surg. 1976 Sep;72(3):464-7.

PMID:
957762
2.

Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.

Heissenbuttel RH, Bigger JT Jr.

Ann Intern Med. 1979 Aug;91(2):229-38. Review.

PMID:
380436
3.

[Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].

Li SZ, Xu XH.

Zhonghua Xin Xue Guan Bing Za Zhi. 1987 Aug;15(4):203-4, 12. Chinese. No abstract available.

PMID:
3440418
4.

Failure of bretylium to suppress inducible ventricular tachycardia.

Greene HL, Werner JA, Gross BW, Sears GK.

Am Heart J. 1983 May;105(5):717-21.

PMID:
6846114
5.

Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.

Vincent JL, Dufaye P, Berre J, Kahn RJ.

Am J Emerg Med. 1984 Nov;2(6):504-6.

PMID:
6529463
6.

Bretylium tosylate: a review.

Bryan CK, Darby MH.

Am J Hosp Pharm. 1979 Sep;36(9):1189-92. Review.

PMID:
386786
7.

Quinidine syncope; report of a case successfully treated with lidocaine.

Kaplinsky E, Yahini JH, Barzilai J, Neufeld HN.

Chest. 1972 Dec;62(6):764-6. No abstract available.

PMID:
4635436
8.

Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.

Patterson E, Gibson JK.

Circulation. 1981 Nov;64(5):1045-50.

PMID:
7285294
9.

Quinidine-induced syncope.

Swiryn S, Kim SS.

Arch Intern Med. 1983 Feb;143(2):314-6. No abstract available.

PMID:
6824397
10.

Effect of quinidine and bretylium on defibrillation energy requirements.

Dorian P, Fain ES, Davy JM, Winkle RA.

Am Heart J. 1986 Jul;112(1):19-25.

PMID:
3728282
11.

Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate.

Goldberger AL, Pavelec RS.

Int J Cardiol. 1986 Oct;13(1):47-55.

PMID:
3771001
12.

Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.

Anderson JL, Popat KD, Pitt B.

Arch Intern Med. 1981 May;141(6):801-2.

PMID:
7235792
13.

Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia.

Bauernfeind RA, Hoff JV, Swiryn S, Palileo E, Strasberg B, Scagliotti D, Rosen KM.

Am Heart J. 1983 Jun;105(6):973-80.

PMID:
6858846
14.
15.

Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.

Dhurandhar RW, Pickron J, Goldman AM.

Heart Lung. 1980 Mar-Apr;9(2):265-70.

PMID:
6898604
16.

Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.

Puddu PE, Jouve R, Saadjian A, Torresani J.

J Pharmacol. 1986 Jul-Sep;17(3):223-43.

PMID:
3795968
17.

[Bretylium tosylate as an anti-arrhythmic drug].

Steffen V, Fiehring H.

Z Gesamte Inn Med. 1976 Nov 15;31(22):913-9. Review. German.

PMID:
798429
18.

[Clinical experiences with bretylium tosylate].

Steffen V, Assmann I, Fiehring H.

Z Gesamte Inn Med. 1976 Sep 1;31(17):684-8. German.

PMID:
793213
19.

Therapy of ventricular tachycardia.

Castle L.

Am J Cardiol. 1984 Jul 30;54(2):26A-33A.

PMID:
6464997
20.
Items per page

Supplemental Content

Support Center